CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
MUTAPREDICT is an innovative platform that uses artificial intelligence and whole genome sequencing data to predict the mutagenic potential of new pharmaceuticals. This approach aims to enhance drug safety assessments while reducing reliance on animal testing, ultimately streamlining the drug development process.
Assessing mutagenicity, the capacity of a substance to cause permanent and potentially harmful changes to an organism's DNA, is a pivotal concern in drug development.
This assessment is crucial because it helps to predict the carcinogenic potential of new pharmaceuticals, ensuring that they are safe for human use.
The importance of evaluating mutagenicity in drug development cannot be overstated.
Drugs are designed to interact with biological systems to treat or prevent diseases, but they must d…
PrinsesMaximaCentrumvoorKinderoncologie
PRINSES MAXIMA CENTRUM VOOR KINDERONCOLOGIE BV
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
